Select Page

All News

MeCRU Research Unit Officially launched as Paediatric COVID-19 VACCINE Trial Site

MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.

Related News

Comrades Marathon boosts SMU physiotherapy training

Comrades Marathon boosts SMU physiotherapy training

Sefako Makgatho Health Sciences University (SMU) Physiotherapy students gained invaluable practical experience at the 2026 Comrades Marathon, reinforcing the University's commitment to academic excellence, experiential learning and community service. Through their...

Research excellence elevates School of Medicine

Research excellence elevates School of Medicine

The School of Medicine at Sefako Makgatho Health Sciences University (SMU) continues to cement its position as a leading centre for medical education, healthcare training and interdisciplinary research, with a growing number of doctoral graduates contributing...

Optimal control research thrives at SMU

Optimal control research thrives at SMU

Sefako Makgatho Health Sciences University (SMU) reaffirmed its commitment to research excellence and innovation when its Department of Mathematics and Applied Mathematics hosted the "Optimal Control and Optimisation: Theory, Algorithms and Applications" research...